연구동향 분석

Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Beh?et’s Disease

이현정 천재희 신혜선 장희원 김승원 박수정 홍성필 김태일 김원호 2014년

논문상세정보
인용/피인용
' Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Beh?et’s Disease' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • c-reactive protein
  • endoscopicactivity
  • erythrocytesedimentationrate
  • intestinalbeh?etsdisease
  • triggeringreceptorexpressedonmyeloidcells-1
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,684 0

0.0%

' Correlation between Soluble Triggering Receptor Expressed on Myeloid Cells-1 and Endoscopic Activity in Intestinal Beh?et’s Disease' 의 참고문헌

  • TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases
    Schenk M J Clin Invest 117 3097-3106 [2007]
  • Surface triggering receptor expressed on myeloid cells 1 expression patterns in septic shock
    Gibot S Intensive Care Med 31 594-597 [2005]
  • Soluble triggering receptor expressed on myeloid cells and the diagnosis of pneumonia
    Gibot S N Engl J Med 350 451-458 [2004]
  • Role of soluble triggering receptor expressed on myeloid cells in inflammatory bowel disease
    Tzivras M World J Gastroenterol 12 3416-3419 [2006]
  • Role of endoscopy in predicting the disease course in inflammatory bowel disease
    Allez M World J Gastroenterol 16 2626-2632 [2010]
  • Review article: biological activity markers in inflammatory bowel disease
    Desai D Aliment Pharmacol Ther 25 247-255 [2007]
  • Recent Advances of Endoscopy in Inflammatory Bowel Diseases
    천재희 Gut and Liver 1 2 118-125 [2007]
  • Prognostic factors and long-term clinical outcomes for surgical patients with intestinal Behcet’s disease
    Jung YS Inflamm Bowel Dis 17 1594-1602 [2011]
  • Prediction of free bowel perforation in patients with intestinal Behçet’s disease using clinical and colonoscopic findings
    Moon CM Dig Dis Sci 55 2904-2911 [2010]
  • Plasma soluble triggering receptor expressed on myeloid cells-1 in Crohn’s disease
    Billioud V Dig Liver Dis 44 466-470 [2012]
  • Phagocyte-specific S100 proteins are released from affected mucosa and promote immune responses during inflammatory bowel disease
    Foell D J Pathol 216 183-192 [2008]
  • Outcome Predictors for Intestinal Behçet’s Disease
    박재준 Yonsei Medical Journal 54 5 1084-1090 [2013]
  • Mucosal healing in inflammatory bowel diseases: a systematic review
    Neurath MF Gut 61 1619-1635 [2012]
  • Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort
    Frøslie KF Gastroenterology 133 412-422 [2007]
  • Mimicry and deception in inflammatory bowel disease and intestinal Behçet disease
    Grigg EL Gastroenterol Hepatol (N Y) 8 103-112 [2012]
  • Laboratory markers in IBD: useful, magic, or unnecessary toys?
    Vermeire S Gut 55 426-431 [2006]
  • Irritable bowel syndrome: epidemiology, diagnosis and treatment: an update for health-care practitioners
    Grundmann O J Gastroenterol Hepatol 25 691-699 [2010]
  • Intestinal involvement in Behçet’s disease: review of 136 surgical cases in the Japanese literature
    Kasahara Y Dis Colon Rectum 24 103-106 [1981]
  • How can IBD be distinguished from IBS?
    Ginsburg PM Inflamm Bowel Dis 14 Suppl 2 S152-S154 [2008]
  • Gastrointestinal manifestations of Behçet’s disease
    Ebert EC. Dig Dis Sci 54 201-207 [2009]
  • Expression of a soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) correlates with clinical disease activity in intestinal Behcet’s disease
    Jung YS Inflamm Bowel Dis 17 2130-2137 [2011]
  • Elevated synovial expression of triggering receptor expressed on myeloid cells 1 in patients with septic arthritis or rheumatoid arthritis
    Collins CE Ann Rheum Dis 68 1768-1774 [2009]
  • Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity
    Saurer L J Crohns Colitis 6 913-923 [2012]
  • Development, validation, and responsiveness of a novel disease activity index for intestinal Behçet’s disease
    Cheon JH Inflamm Bowel Dis 17 605-613 [2011]
  • Development and validation of novel diagnostic criteria for intestinal Behçet’s disease in Korean patients with ileocolonic ulcers
    Cheon JH Am J Gastroenterol 104 2492-2499 [2009]
  • Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
    Bouchon A J Immunol 164 4991-4995 [2000]
  • Correlations between endoscopic and clinical disease activity indices in intestinal Behcet’s disease
    Lee HJ World J Gastroenterol 18 5771-5778 [2012]
  • Correlation of Serum-Soluble Triggering Receptor Expressed on Myeloid Cells-1 with Clinical Disease Activity in Inflammatory Bowel Disease
    Park JJ DIGESTIVE DISEASES AND SCIENCES 54 1525-1531 [2009]
  • Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease
    Solem CA Inflamm Bowel Dis 11 707-712 [2005]
  • Correlation between soluble triggering receptor expressed on myeloid cells-1 (sTREM-1) expression and endoscopic activity in inflammatory bowel diseases
    Jung YS DIGESTIVE AND LIVER DISEASE 44 11 897-903 [2012]
  • Anti-Saccharomyces cerevisiae antibody in intestinal Behçet’s disease patients: relation to clinical course
    Choi CH Dis Colon Rectum 49 1849-1859 [2006]